Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - technology+classifications+%3e+medical+%3e+endocrinology
11
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Salivary Biomarkers Associated with Glycemic Control and Oral Health
Competitive Advantages Obtained from saliva Could be developed as a method to evaluate glucose control Potential to be a diagnostic for oral health Summary USF inventors have demonstrated a relationship between inflammation, glucose marker HbA1c, and gum health when the saliva of patients with type I Diabetes was analyzed. There is an increase...
Published: 8/26/2023
|
Inventor(s):
Brant Burkhardt
,
Amy Alman
Keywords(s):
Category(s):
Technology Classifications > Medical > Endocrinology
,
Technology Classifications > Medical > Medical Diagnostics
Silicon Carbide Nanoparticles Fibrous Membrane for Implantable Glucose Sensor Integrated with Chronoamperometric Potentiostat
Competitive Advantages Longer durability of sensor Better sensitivity hence, better and more reliable results The SiCNPs-ENFM based sensor has lower power consumption thus making it cost effective Summary For a glucose sensor to be an effective part of managing a patient’s diabetes mellitus it needs to be power efficient, compact, portable,...
Published: 5/21/2024
|
Inventor(s):
Kavyashree Puttananjegowda
,
Sylvia Thomas
,
Arash Takshi
Keywords(s):
Diabetes
,
Medical Diagnostics
,
Sensors
Category(s):
Technology Classifications > Medical > Medical Devices
,
Technology Classifications > Medical > Endocrinology
,
Technology Classifications > Medical > Medical Sensors
System and Method for Non-invasive Blood Glucose Monitoring
Advantages Battery-less maintenance-free low production and maintenance cost system Accurate real-time measurements Completely wireless operation in no-cost unlicensed bands Summary Our researchers have developed a novel glucose monitoring system with the antenna on the external surface of the body. The glucose concentration in the blood is...
Published: 4/30/2024
|
Inventor(s):
Stephen Saddow
,
Fabiola Araujo Cespedes
,
Gokhan Mumcu
,
Christopher Frewin
Keywords(s):
Category(s):
Technology Classifications > Medical > Endocrinology
,
Technology Classifications > Medical
Ultra Low Noise Transimpedence Amplifier for Blood Glucose Monitoring Systems
Competitive Advantages High sensitivity Low power consumption Improved accuracy and range for blood glucose measurements Decreased noise from measurements Summary USF inventors have created an ultra low noise and power transimpedance amplifier (TIA) to be used with a glucose meter. A multistage complementary metal-oxide-semiconductor (CMOS)...
Published: 6/1/2023
|
Inventor(s):
Sylvia Thomas
,
Kavyashree Puttananjegowda
Keywords(s):
Category(s):
Technology Classifications > Computer Science > C/S Sensors
,
Technology Classifications > Medical > Endocrinology
,
Technology Classifications > Medical
,
Technology Classifications > Computer Science
aPKC Inhibitor for Treatment of Diabetes and Neurodegenerative Diseases and Disorders
Competitive Advantages Reduces both hyperinsulinemia & AD pathology Blood-Brain Barrier permeable Bimolecular specific inhibitor Prevents neurodegeneration Summary Numerous conclusions obtained from clinical data indicate a link between insulin resistance and an increase in Alzheimer’s disease (AD) susceptibility. An overexpression...
Published: 8/25/2023
|
Inventor(s):
Robert Farese
,
Mini Sajan
,
Margaret Higgs
Keywords(s):
Category(s):
Technology Classifications > Medical > Endocrinology
,
Technology Classifications > Medical
Cardioprotective Activity of Nampt Activator in Diabetic Mice
Competitive Advantages Increased cardio protection Provides improved glucose tolerance An anti-diabetic agent Safe for long term use Summary USF researchers have investigated a novel pharmaceutical compound, known as P7C3. This compound was found to be a nicotinamide phosporiibosyltransferese (Nampt) activator and exhibited...
Published: 8/25/2023
|
Inventor(s):
Srinivas Tipparaju
,
Jared Tur
,
Kalyan Chapalamadugu
,
Sachin Badole
Keywords(s):
Category(s):
Technology Classifications > Medical > Endocrinology
,
Technology Classifications > Medical
GAS5-binding Small Molecule for Treatment of Diabetes and Cancer
Competitive Advantages Stabilize and increase Gas5 levels Controls glucose metabolism and uptake Multi-faceted and specific therapy Promotes Apoptosis Summary A technique has been developed to diagnose and predict type-2 diabetes mellitus via human GAS5; a long noncoding RNA(LncRNAs). LncRNAs are transcribed by all cell types however their...
Published: 8/22/2024
|
Inventor(s):
Niketa Patel
Keywords(s):
Category(s):
Technology Classifications > Cancer
,
Technology Classifications > Medical > Endocrinology
,
Technology Classifications > Medical
Sortilin-Binding Small Molecule Increases Glucose Uptake
Competitive Advantages Selectively binds to wild-type sortilin Increases cellular glucose uptake Compensates for reduced sortilin activity in obese patients Summary USF inventors have discovered novel therapeutic compounds that have shown to bind favorably to wild-type (WT) sortilin and increase glucose uptake, especially when used...
Published: 8/26/2023
|
Inventor(s):
Robert Sparks
,
Wayne Guida
,
Niketa Patel
Keywords(s):
Category(s):
Technology Classifications > Medical > Endocrinology
,
Technology Classifications > Medical > Pharmaceuticals
,
Technology Classifications > Medical
Gas5 lncRNA Biomarker Signature for Prediction and Management of Diabetes
Competitive Advantages Establishes GAS5 a circulating biomarker in blood, urine, or saliva Easy integration into routine care to assess risk of developing diabetes Non-invasive biomarker that predicts pre-diabetic and diabetic conditions Summary Our inventors have identified GAS5, an RNA-based biofluid marker for prediction and management of...
Published: 8/2/2024
|
Inventor(s):
Niketa Patel
Keywords(s):
Category(s):
Technology Classifications > Medical > Endocrinology
,
Technology Classifications > Medical
Treatment of Metabolic Diseases with 5-Aminolevulinate Synthase Inhibitors
Competitive Advantages Effectively inhibits ALAS Treats heme biosynthesis disorders and other ALAS related diseases Easy synthesis and purification technique Summary USF scientists have discovered inhibitors against 5-aminolevulinate synthase. This was achieved via a kinetic target -guided synthesis that was extended to multi-fragment screening...
Published: 6/7/2023
|
Inventor(s):
Roman Manetsch
,
Gloria Ferreira
Keywords(s):
Category(s):
Technology Classifications > Medical > Pharmaceuticals
,
Technology Classifications > Medical > Endocrinology
,
Technology Classifications > Medical
1
2